首页> 美国卫生研究院文献>other >Evolution under drug pressure remodels the folding free-energy landscape of mature HIV-1 protease
【2h】

Evolution under drug pressure remodels the folding free-energy landscape of mature HIV-1 protease

机译:药物压力下的进化重塑了成熟HIV-1蛋白酶的折叠自由能态

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Using high-pressure NMR spectroscopy and differential scanning calorimetry, we investigate the folding landscape of the mature HIV-1 protease homodimer. The cooperativity of unfolding was measured in the absence or presence of an active site inhibitor DMP323, for the active protease (PR), its inactive variant PRD25N and an extremely multi-drug resistant mutant, PR20. The individual fit of the pressure denaturation profiles gives rise to first order, ΔGNMR, and second order, ΔVNMR (the derivative of ΔGNMR with pressure) apparent thermodynamic parameters for each amide proton considered. Heterogeneity in the apparent ΔVNMR values reflects departure from an ideal cooperative unfolding transition. The narrow to broad distribution of ΔVNMR spanning the extremes from inhibitor-free PR20D25N to PR-DMP323 complex, and distinctively for PRD25N-DMP323 complex, indicated large variations in folding cooperativity. Consistent with this data, the shape of thermal unfolding transitions varies from asymmetric for PR to nearly symmetric for PR20, as dimer-inhibitor ternary complexes. Lack of structural cooperativity was observed between regions located close to the active site, including the hinge and tip of the glycine-rich flaps, and the rest of the protein. These results strongly suggest that inhibitor binding drastically decreases the cooperativity of unfolding by trapping the closed flap conformation in a deep energy minimum. To evade this conformational trap, PR20 evolves exhibiting a smoother folding landscape with nearly an ideal two-state (cooperative) unfolding transition. This study highlights the malleability of retroviral protease folding pathways by illustrating how the selection of mutations under drug pressure remodels the free-energy landscape as a primary mechanism.
机译:使用高压NMR光谱和差示扫描量热法,我们研究了成熟的HIV-1蛋白酶同源二聚体的折叠态。在不存在或存在活性位点抑制剂DMP323的情况下,针对活性蛋白酶(PR),其无活性变异体PRD25N和极耐多种药物的突变体PR20,测量了展开的协同性。对于所考虑的每个酰胺质子,压力变性曲线的个体拟合得出一阶ΔGNMR和二阶ΔVNMR(ΔGNMR随压力的导数)表观热力学参数。表观ΔVNMR值的异质性反映了与理想的协同展开过渡的偏离。 ΔVNMR从无抑制剂的PR20D25N到PR-DMP323复合物的极值,从窄到宽分布,并且对于PRD25N-DMP323复合物具有明显的区别,表明折叠协同性有很大差异。与此数据一致,热展开转变的形状从PR的不对称变化到PR20的近对称变化,为二聚体抑制剂三元复合物。在靠近活性位点的区域之间,包括富含甘氨酸的皮瓣的铰链和尖端,以及其余的蛋白质之间,观察到缺乏结构上的协同作用。这些结果有力地表明,抑制剂的结合通过将闭合的皮瓣构象捕获在最低能量中而大大降低了展开的协同作用。为了逃避这种构象陷阱,PR20不断发展,展现出一种更为平滑的折叠环境,并具有理想的两态(合作)展开过渡。这项研究通过说明在药物压力下选择突变如何重塑自由能格局作为主要机制,突出了逆转录病毒蛋白酶折叠途径的可塑性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号